(Q52030298)

20 April 2018

title

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy. (English)

1 reference

20 April 2018

0 references

1 reference

Claudio Velati

1

1 reference

20 April 2018

Luisa Romanò

2

1 reference

20 April 2018

Lorella Baruffi

3

1 reference

20 April 2018

Marco Pappalettera

4

1 reference

20 April 2018

Vittorio Carreri

5

1 reference

20 April 2018

Alessandro R Zanetti

6

1 reference

20 April 2018

publication date

1 August 2002

1 reference

20 April 2018

published in

Transfusion

1 reference

20 April 2018

volume

42

1 reference

20 April 2018

issue

8

1 reference

20 April 2018

page(s)

989-993

1 reference

20 April 2018

Safety of the blood supply in the United States: opportunities and controversies

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

Incidence of transfusion associated B and non-A, non-B hepatitis in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

Efficacy of HCV core antigen detection during the preseroconversion period

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

Transfusion medicine. First of two parts--blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

Prevalence of hepatitis A, B and C in the Flemish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00173.X

10.1046/J.1537-2995.2002.00173.X

21 January 2018

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018